Insider filing · TRDA
Andrew J. Schwab
Director
profile →
Entrada Therapeutics, Inc.
TRDA · Healthcare · 31 filings in 24 months
ticker →
Andrew J. Schwab sold $777K of Entrada Therapeutics (TRDA)
Executed Jun 27 2025, disclosed Jul 1 2025, 4 days later.
Value, as filed
$777K
112,156 sh across 4 lots
Executed
Jun 27 2025
the trade date, as filed
Disclosed
Jul 1 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ASAndrew J. Schwab (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). The largest single filing was $1.6M of CAMP (400,000 sh × $4.04, as filed), executed Aug 27.
The name
TRDAHealthcare · Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new c…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→